Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisolone in Allergic Conjunctivitis (Modified CAC Model)
NCT01534195Phase 4Completed
- Start
- Jan 2012
- Primary completion
- Feb 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisolone sodium phosphate in allergic conjunctivitis (AC). Started Jan 2012; status: completed.
02
Drugs
prednisolone sodium phosphate
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT01534195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01534195.